Compare SGU & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGU | ABSI |
|---|---|---|
| Founded | 1995 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 422.1M | 418.0M |
| IPO Year | 1997 | 2021 |
| Metric | SGU | ABSI |
|---|---|---|
| Price | $13.04 | $2.66 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $7.98 |
| AVG Volume (30 Days) | 28.1K | ★ 2.9M |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | ★ 5.67% | N/A |
| EPS Growth | N/A | ★ 21.67 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,784,418,000.00 | $4,534,000.00 |
| Revenue This Year | N/A | $10.72 |
| Revenue Next Year | N/A | $313.07 |
| P/E Ratio | $6.70 | ★ N/A |
| Revenue Growth | ★ 1.04 | N/A |
| 52 Week Low | $11.31 | $2.01 |
| 52 Week High | $13.75 | $5.23 |
| Indicator | SGU | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 56.83 | 43.39 |
| Support Level | $12.66 | $2.40 |
| Resistance Level | $13.05 | $2.79 |
| Average True Range (ATR) | 0.31 | 0.20 |
| MACD | -0.05 | 0.02 |
| Stochastic Oscillator | 41.09 | 35.90 |
Star Group LP is a home heating oil and propane distributor and services provider with one reportable operating segment that principally provides heating related services to residential and commercial customers. It serves residential and commercial customers whose primary use is to heat their homes and buildings in the Northeast and Mid-Atlantic U.S. regions. The company derives the majority of revenue from Petroleum products, which consist of home heating oil and propane as well as diesel fuel and gasoline.
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.